HIND
Vyome Holdings, Inc.
Price Chart
Latest Quote
$2.11
-0.01 (-0.47%)
Current Price
| Previous Close | $2.12 |
| Open | $2.16 |
| Day High | $2.16 |
| Day Low | $2.10 |
| Volume | 31,845 |
Stock Information
| Shares Outstanding | 7.02M |
| Total Debt | $23K |
| Cash Equivalents | $8.80M |
| Revenue | $153K |
| Net Income | $-10.93M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $14.74M |
| EPS (TTM) | $-1.56 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.40M |
| Sales | $153K |
| Income | $-10.93M |
| Book/sh | $0.96 |
| Cash/sh | $1.25 |
| Employees | 9 |
Financial Ratios
| Quick Ratio | 4.17 |
| Current Ratio | 4.27 |
| Debt/Eq | 0.28 |
Returns & Margins
| ROA | -39.54% |
| ROE | -665.57% |
| Gross Margin | 53.03% |
| Operating Margin | -3576.78% |
Ownership
| Insider Ownership | 52.89% |
| Institutional Ownership | 1.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 96.51 |
| P/B | 2.19 |
Analyst Data
| Recommendation | none |
| Target Price | $11.50 |
Technical Indicators
| SMA20 | $2.22 |
| SMA50 | $2.16 |
| SMA200 | $3.61 |
| RSI | 39.19 |
| ATR | 0.1624 |
| Shares Float | 3.25M |
| Short Float | 1.72% |
| Short Ratio | 2.10 |
| Rel Volume | 1.42 |
Performance History
| Week | -4.55% |
| Month | -5.83% |
| Quarter | -8.30% |
| 6 Months | -42.93% |
| YTD | -40.85% |
| Year | -79.49% |
| 3 Years | -99.98% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $2.10 | 33,266 |
| 2026-06-23 | $2.12 | 45,800 |
| 2026-06-22 | $2.17 | 15,200 |
| 2026-06-18 | $2.17 | 26,400 |
| 2026-06-17 | $2.18 | 29,200 |
| 2026-06-16 | $2.20 | 10,200 |
| 2026-06-15 | $2.17 | 15,300 |
| 2026-06-12 | $2.30 | 8,300 |
| 2026-06-11 | $2.28 | 13,200 |
| 2026-06-10 | $2.17 | 12,900 |
| 2026-06-09 | $2.11 | 9,800 |
| 2026-06-08 | $2.19 | 63,900 |
| 2026-06-05 | $2.16 | 14,300 |
| 2026-06-04 | $2.30 | 19,700 |
| 2026-06-03 | $2.26 | 49,500 |
| 2026-06-02 | $2.30 | 23,200 |
| 2026-06-01 | $2.32 | 14,700 |
| 2026-05-29 | $2.34 | 21,700 |
| 2026-05-28 | $2.35 | 23,900 |
| 2026-05-27 | $2.24 | 17,200 |
| 2026-05-26 | $2.31 | 32,700 |
About Vyome Holdings, Inc.
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
đ° Latest News
Vyome Holdings Inc (HIND) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
GuruFocus.com âĸ 2026-03-30T23:00:38ZWe're Not Very Worried About Vyome Holdings' (NASDAQ:HIND) Cash Burn Rate
Simply Wall St. âĸ 2025-12-29T11:02:45Z
Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market
Investing.com âĸ 2025-08-15T18:57:08Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $100,943 | $61,974 | $133,408 | $236,746 |
| Cost Of Revenue | $100,943 | $61,974 | $133,408 | $236,746 |
| Total Revenue | $319,714 | $256,944 | $415,940 | $382,865 |
| Operating Revenue | $319,714 | $256,944 | $415,940 | $382,865 |
| Expenses | ||||
| Interest Expense | $146,641 | $206,004 | $164,680 | $124,981 |
| Total Expenses | $3,066,751 | $1,263,284 | $1,183,658 | $1,487,048 |
| Other Income Expense | $-7,584,035 | $-235,117 | $212,478 | $-26,134 |
| Other Non Operating Income Expenses | $121,498 | $-235,117 | $212,478 | $-26,134 |
| Net Non Operating Interest Income Expense | $-146,641 | $-206,004 | $-164,680 | $-124,981 |
| Interest Expense Non Operating | $146,641 | $206,004 | $164,680 | $124,981 |
| Operating Expense | $2,965,808 | $1,201,310 | $1,050,250 | $1,250,302 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,262,007 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Net Interest Income | $-146,641 | $-206,004 | $-164,680 | $-124,981 |
| Normalized Income | $-2,556,474 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Net Income From Continuing And Discontinued Operation | $-10,262,007 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Total Operating Income As Reported | $-10,452,570 | $-1,006,340 | $-767,718 | $-1,104,183 |
| Net Income Common Stockholders | $-10,262,007 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Net Income | $-10,262,007 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Net Income Including Noncontrolling Interests | $-10,477,713 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Net Income Continuous Operations | $-10,477,713 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Pretax Income | $-10,477,713 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Special Income Charges | $-7,705,533 | $0 | - | - |
| Operating Income | $-2,747,037 | $-1,006,340 | $-767,718 | $-1,104,183 |
| Depreciation Amortization Depletion Income Statement | $11,985 | $17,347 | - | - |
| Depreciation And Amortization In Income Statement | $11,985 | $17,347 | - | - |
| Gross Profit | $218,771 | $194,970 | $282,532 | $146,119 |
| Per Share | ||||
| Diluted EPS | $-4.86 | $-0.26 | $-0.03 | $-0.05 |
| Basic EPS | $-4.86 | $-0.26 | $-0.03 | $-0.05 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,613,554 | $-1,224,110 | $-534,047 | $-1,074,169 |
| Total Unusual Items | $-7,705,533 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-7,705,533 | $0 | - | - |
| Reconciled Depreciation | $11,985 | $17,347 | $21,193 | $56,148 |
| EBITDA (Bullshit earnings) | $-10,319,087 | $-1,224,110 | $-534,047 | $-1,074,169 |
| EBIT | $-10,331,072 | $-1,241,457 | $-555,240 | $-1,130,317 |
| Diluted Average Shares | $2,161,342 | $5,565,597 | $26,368,147 | $26,368,147 |
| Basic Average Shares | $2,161,342 | $5,565,597 | $26,368,147 | $26,368,147 |
| Diluted NI Availto Com Stockholders | $-10,262,007 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Minority Interests | $215,706 | $0 | - | - |
| Restructuring And Mergern Acquisition | $7,705,533 | $0 | - | - |
| Research And Development | $588,258 | $285,391 | $294,445 | $423,700 |
| Selling General And Administration | $2,365,565 | $898,572 | $755,805 | $826,602 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,127,868 | $-4,705,225 | $-6,399,363 | $-5,679,279 |
| Total Assets | $6,497,177 | $1,381,561 | $1,421,251 | $1,789,415 |
| Total Non Current Assets | $1,058,856 | $1,079,515 | $1,251,425 | $1,258,204 |
| Non Current Prepaid Assets | $67,307 | $0 | - | - |
| Non Current Accounts Receivable | $601,537 | $646,758 | $697,827 | $734,372 |
| Goodwill And Other Intangible Assets | $314,191 | $314,191 | $314,191 | $314,191 |
| Current Assets | $5,438,321 | $302,046 | $169,826 | $531,211 |
| Other Current Assets | $17,428 | $16,612 | $86,363 | $40,691 |
| Current Deferred Assets | $0 | $111,415 | - | - |
| Prepaid Assets | $339,949 | $21,173 | $0 | $32,154 |
| Receivables | $98,611 | $50,942 | $66,816 | $122 |
| Other Receivables | $98,286 | $48,648 | - | - |
| Accounts Receivable | $325 | $2,294 | $66,816 | $122 |
| Cash Cash Equivalents And Short Term Investments | $4,982,333 | $101,904 | $16,647 | $458,244 |
| Cash And Cash Equivalents | $4,982,333 | $101,904 | $16,647 | $458,244 |
| Non Current Deferred Assets | - | - | $66,415 | $66,415 |
| Debt | ||||
| Total Debt | $31,258 | $3,650,264 | $3,017,949 | $2,874,870 |
| Long Term Debt And Capital Lease Obligation | $0 | $32,830 | $1,029,526 | $2,248,695 |
| Current Debt And Capital Lease Obligation | $31,258 | $3,617,434 | $1,988,423 | $626,175 |
| Net Debt | - | $3,487,506 | $2,914,242 | $2,373,961 |
| Current Debt | - | $3,589,410 | $1,963,386 | $583,510 |
| Other Current Borrowings | - | $3,589,410 | $1,963,386 | $583,510 |
| Long Term Debt | - | - | $967,503 | $2,248,695 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,735,160 | $5,772,594 | $7,506,423 | $7,154,503 |
| Total Non Current Liabilities Net Minority Interest | $0 | $32,830 | $1,029,526 | $2,248,695 |
| Current Liabilities | $2,735,160 | $5,739,764 | $6,476,897 | $4,905,808 |
| Other Current Liabilities | $62,452 | $63,795 | $1,749,799 | $1,793,314 |
| Current Deferred Liabilities | $26,086 | $38,358 | - | - |
| Payables And Accrued Expenses | $2,455,709 | $1,878,315 | $2,738,675 | $2,486,319 |
| Payables | $1,816,559 | $1,414,629 | $2,253,476 | $1,973,436 |
| Other Payable | $964,464 | $783,362 | $1,211,205 | $1,009,475 |
| Accounts Payable | $647,533 | $501,921 | $589,839 | $586,310 |
| Equity | ||||
| Common Stock Equity | $2,442,059 | $-4,391,037 | $-53,070,047 | $-52,349,963 |
| Total Equity Gross Minority Interest | $3,762,017 | $-4,391,033 | $-6,085,172 | $-5,365,088 |
| Stockholders Equity | $2,442,059 | $-4,391,034 | $-6,085,172 | $-5,365,088 |
| Gains Losses Not Affecting Retained Earnings | $-78,864 | $-53,170 | $212,248 | $212,412 |
| Other Equity Adjustments | $-78,864 | $-53,170 | $212,248 | $212,412 |
| Retained Earnings | $-87,563,575 | $-55,422,744 | $-53,927,896 | $-53,207,976 |
| Preferred Stock Equity | - | $3 | $46,984,875 | $46,984,875 |
| Other | ||||
| Ordinary Shares Number | $5,919,337 | $5,565,597 | $26,368,147 | $26,368,147 |
| Share Issued | $5,919,337 | $5,565,597 | $26,368,147 | $26,368,147 |
| Tangible Book Value | $2,127,868 | $-4,705,228 | $-53,384,238 | $-52,664,154 |
| Invested Capital | $2,442,059 | $-801,627 | $-50,139,158 | $-49,517,758 |
| Working Capital | $2,703,161 | $-5,437,718 | $-6,307,071 | $-4,374,597 |
| Capital Lease Obligations | $31,258 | $60,854 | $87,060 | $42,665 |
| Total Capitalization | $2,442,059 | $-4,391,034 | $-5,117,669 | $-3,116,393 |
| Minority Interest | $1,319,958 | $1 | - | - |
| Additional Paid In Capital | $90,078,579 | $51,084,877 | $643,709 | $643,709 |
| Capital Stock | $5,919 | $3 | $46,986,767 | $46,986,767 |
| Common Stock | $5,919 | $0 | $1,892 | $1,892 |
| Preferred Stock | $0 | $3 | $46,984,875 | $46,984,875 |
| Long Term Capital Lease Obligation | $0 | $32,830 | $62,023 | $0 |
| Current Deferred Revenue | $26,086 | $38,358 | - | - |
| Current Capital Lease Obligation | $31,258 | $28,024 | $25,037 | $42,665 |
| Pensionand Other Post Retirement Benefit Plans Current | $159,655 | $141,862 | - | - |
| Current Accrued Expenses | $639,150 | $463,686 | $485,199 | $512,883 |
| Dueto Related Parties Current | $204,562 | $129,346 | $452,432 | $377,651 |
| Net PPE | $75,821 | $118,566 | $172,992 | $143,226 |
| Accumulated Depreciation | $-524,309 | $-547,716 | $-662,199 | $-641,166 |
| Gross PPE | $600,130 | $666,282 | $835,191 | $784,392 |
| Other Properties | $421,539 | $471,227 | $575,813 | $524,653 |
| Machinery Furniture Equipment | $55,982 | $66,277 | $98,920 | $99,281 |
| Buildings And Improvements | $122,609 | $128,778 | $160,458 | $160,458 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,748,853 | $-614,136 | $-563,983 | $-362,879 |
| Operating Activities | ||||
| Operating Cash Flow | $-3,748,853 | $-614,136 | $-563,983 | $-362,879 |
| Cash Flow From Continuing Operating Activities | $-3,748,853 | $-614,136 | $-563,983 | $-362,880 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $315 | $201 | $68 |
| Cash Flow From Continuing Investing Activities | $0 | $315 | $201 | $68 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,857,714 | $0 | - | - |
| Financing Cash Flow | $8,654,976 | $697,951 | $122,349 | $752,651 |
| Cash Flow From Continuing Financing Activities | $8,654,976 | $697,951 | $122,349 | $752,651 |
| Net Common Stock Issuance | $7,857,714 | $0 | - | - |
| Common Stock Issuance | $7,857,714 | $0 | - | - |
| Net Other Financing Charges | - | $30,942 | $-27,651 | $27,651 |
| Other | ||||
| Issuance Of Debt | $791,253 | $667,009 | $150,000 | $725,000 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $4,982,333 | $101,904 | $16,647 | $458,244 |
| Beginning Cash Position | $101,904 | $16,647 | $458,244 | $68,197 |
| Effect Of Exchange Rate Changes | $-25,694 | $1,127 | $-164 | $208 |
| Changes In Cash | $4,906,123 | $84,130 | $-441,433 | $389,839 |
| Proceeds From Stock Option Exercised | $6,009 | $0 | - | - |
| Net Issuance Payments Of Debt | $791,253 | $667,009 | $150,000 | $725,000 |
| Net Short Term Debt Issuance | $191,253 | $667,009 | $150,000 | $725,000 |
| Short Term Debt Issuance | $191,253 | $667,009 | $150,000 | $725,000 |
| Net Long Term Debt Issuance | $600,000 | $0 | $150,000 | $725,000 |
| Long Term Debt Issuance | $600,000 | $0 | $150,000 | $725,000 |
| Net PPE Purchase And Sale | $0 | $315 | $201 | $68 |
| Sale Of PPE | $0 | $315 | $201 | $68 |
| Change In Working Capital | $39,905 | $390,388 | $186,062 | $539,901 |
| Change In Other Working Capital | $-48,618 | $197,935 | $204,283 | $211,433 |
| Change In Other Current Liabilities | $200,551 | $12,137 | $882 | $-67,526 |
| Change In Other Current Assets | $75,982 | $78,742 | $-14,615 | $-36,689 |
| Change In Payables And Accrued Expense | $246,558 | $37,111 | $75,724 | $204,209 |
| Change In Payable | $246,558 | $37,111 | $75,724 | $204,209 |
| Change In Account Payable | $171,342 | $-58,861 | $-26,708 | $104,209 |
| Change In Prepaid Assets | $-434,568 | $64,463 | $-13,518 | $205,945 |
| Other Non Cash Items | $100,148 | $425,590 | $-51,318 | $271,358 |
| Stock Based Compensation | $6,576,822 | $0 | $0 | $25,012 |
| Depreciation Amortization Depletion | $11,985 | $17,347 | $21,193 | $56,148 |
| Depreciation And Amortization | $11,985 | $17,347 | $21,193 | $56,148 |
| Net Income From Continuing Operations | $-10,477,713 | $-1,447,461 | $-719,920 | $-1,255,298 |
| Change In Inventory | - | - | $0 | $22,605 |
| Change In Receivables | - | - | $-66,694 | $-76 |
| Changes In Account Receivables | - | - | $-66,694 | $-76 |
Fetched: 2026-06-20